By Alan Mozes

HealthDay Reporter

TUESDAY, June 23, 2020 (HealthDay Information) — Could a most cancers drug spare medical center people from the ravages of intense COVID-19?

Yale medical professionals feel it can just after providing the treatment, acknowledged as tocilizumab, to severely ill people back in March.

How does tocilizumab operate? It has a extended history of dampening the existence-threatening immune process reactions most cancers people normally encounter though undergoing therapy. Since the similar type of unsafe reaction develops in numerous COVID-19 scenarios, the scientists considered the drug could make a big difference for the sickest people.

The final